Vidrala (VID) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Sales for H1 2024 reached €830.4 million, up 4.5% year-over-year, with organic growth of 0.7%.
EBITDA rose 4.6% to €225.0 million, with a stable margin of 27.1%.
Net profit was €120.8 million, with EPS at €3.75, down 6.0% compared to H1 2023.
Net debt as of June 30, 2024, was €433.4 million, leverage at 1.0x EBITDA, reflecting recent M&A and the sale of the Italian segment.
Strategic divestments and acquisitions, including entry into Brazil and sale of Italian operations, strengthened the business profile.
Financial highlights
EBIT for H1 2024 was €164.9 million, with a margin of 19.9%.
Free cash flow for H1 2024 totaled €89.8 million, representing about 11% of sales.
Shareholder cash remuneration in 2024 amounted to €5.45 per share, including an extraordinary dividend.
Earnings per share declined 6.0% to €3.75.
Net debt rose 52.7% year-over-year to €433.4 million.
Outlook and guidance
Full-year 2024 EBITDA guidance reiterated above €450 million.
Free cash flow forecast above €180 million, excluding M&A payments.
FY 2024 sales expected at €1,600 million, with modest volume recovery in Europe & UK and capacity expansion in Brazil.
Earnings per share guidance at €7.00, with double-digit growth in recurrent, adjusted EPS.
Management reiterates guidance despite softer-than-expected global demand, citing improved financial position and readiness for demand recovery.
Latest events from Vidrala
- 2025 saw lower sales but higher margins, reduced debt, and a 15% dividend increase proposal.VID
Q4 202525 Feb 2026 - EBITDA margin hit 27.8% on €1.2B+ sales, EPS rose 26%, and guidance remains robust.VID
Q3 202418 Jan 2026 - EBITDA margin rose to 28.1% and leverage improved despite lower sales and profit.VID
Q1 202527 Dec 2025 - EBITDA up 15.3% to €454M, with record profit, lower debt, and higher shareholder returns.VID
Q4 202423 Dec 2025 - Margins rose to 29.3% and leverage fell to 0.3x EBITDA despite lower sales.VID
Q3 202529 Oct 2025 - EBITDA margin rose and leverage improved, despite lower sales and profit.VID
Q2 202524 Jul 2025